Researchers Consider Graphene as a Cure for Desalination Woes




desalination,freshwater,crisis GOING WITH THE FLOW: Hydrogenated (a) and hydroxylated (b) graphene pores, and (c) side view of the computational system described in this research. Image: Courtesy of the Massachusetts Institute of Technology (M.I.T.)

More In This Article

The earth harbors about 1.4 billion cubic kilometers of water. Unfortunately, the vast majority of that water comes from the sea and is not potable unless treated by expensive, energy-hungry desalination plants. Those problems stem largely from inefficiency in the way salt ions are separated from water molecules, and the solution, says a team of materials scientists from the Massachusetts Institute of Technology, lies in fundamentally revising that process.

The predominant desalination method today—reverse osmosis (RO)—relies on polymer-based membranes to remove salt and requires great pressure to push water through a semipermeable film.The more pressure applied, the higher the cost. The M.I.T. researchers, led by Jeffrey Grossman and David Cohen-Tanugi, propose that films made of graphene could filter out salt without inhibiting the water flow as much. Graphene, a superstrong sheet of carbon that is only one atom thick, has mostly been seen as a material for improving electronics and optical communications.

Reverse osmosis requires less energy than other desalination approaches—such as thermal distillation—but graphene membranes containing nanoscale pores that are more permeable than the polymers currently used would further cut energy requirements, the researchers reported online last month in Nano Letters.

The idea is to discriminate between water molecules and salt ions based on size. "Reverse osmosis uses size exclusion, except it excludes everything," says Grossman, an associate professor of power engineering.

A graphene membrane would provide well-defined channels that allow water molecules to flow through at lower pressures while blocking salt ions, Grossman says.

Using software simulations, the M.I.T. researchers experimented with different pore sizes to desalinate seawater with a salt concentration of 72 grams per liter, about twice the salinity normally found in the ocean. They found that, theoretically at least, pores 0.7 to 0.9 nanometer in diameter were most effective at passing water molecules while blocking sodium ions. "That's the sweet spot," Grossman says. "If it's bigger, salt's going to flow through. If it's smaller, nothing flows through."

Grossman and his team are trying to determine whether chemical reactions might be used to tweak desalination performance. The researchers programmed their digital graphene pores to be coated with either hydrophobic (water-repelling) or hydrophilic (water-loving) atoms. The former slowed the flow but cut down on the salt ions passing through, while the latter allowed faster flow but blocked fewer salt ions. The type of coating may ultimately depend on conditions at a given facility. Still, the scientists report, simulations indicate that graphene nanopores could reject salt ions with a water permeability two-to-three orders of magnitude higher than RO membranes.

Of course, working with graphene in reality is more challenging than filtering pixilated salt from digital water molecules on a computer. For starters, although chemical etching and ion beams can be used to create holes in graphene, it is difficult to produce holes of a specific size in an even configuration, Grossman acknowledges. Nor does graphene eliminate the quandary of how much leftover brine can be safely returned to the ocean without hurting underwater habitats. Toxicity could also be an important issue, he says, "although there are no real answers right now in terms of [graphene's] potential impact on [the safety of] drinking water."

Grossman does not know when graphene-based desalination might be ready for commercial use. He and his team, though, continue to run simulations and have begun testing actual membranes in the lab to study flow rates and salinity.

Demand for potable water is expected to escalate worldwide in the coming years. Grossman says the key to meeting that need is not necessarily tweaking existing technology. "We looked around at who's working on desalination in the scientific community, and it's mostly mechanical engineers working at the systems level," he says. "Little is being done on the system design side using basic science and working from the bottom up."

How Black Holes Help Shape Their Galaxies [Video]

http://bcove.me/58essu3z


Astrophysicist and author Caleb Scharf talks about his article "The Benevolence of Black Holes," in the August issue of Scientific American

Image: Scientific American

Black holes don't just pull stuff in—they also give back. In "The Benevolence of Black Holes," adapted from his new book Gravity's Engines, Caleb Scharf of Columbia University explains how these cosmic heavyweights shape the structures around them by spewing matter and radiation outward. In the video below, Scharf talks about some of the ways a black hole can influence its surroundings.


Implantable Devices Could Detect and Halt Epileptic Seizures

Electrical stimulation, brain "cooling" and drug-delivery devices are all being developed as antiseizure tools

epilepsy,seizure,implant,brain STIMULATING: A new generation of implantable "closed-loop" devices are designed to monitor the seizure focus, detect patterns of electrical activity that indicate a seizure is beginning, and quickly respond without external intervention. Image: Courtesy of Henrik Jonsson, via iStockphoto.com

More In This Article

Epilepsy affects some 2.7 million Americans—more than Parkinson’s disease, multiple sclerosis and amyotrophic lateral sclerosis (Lou Gehrig's disease) combined. More than half of patients can achieve seizure control with treatment, yet almost a third of people with epilepsy have a refractory form of the disease that does not respond well to existing antiepileptic drugs. Nor are these patients typically helped by the one implanted device—Cyberonics' Vagus Nerve Stimulator (VNS)—that has had U.S. Food and Drug Administration approval for treatment of epilepsy since 1997.

Because epilepsy causes repeated, sudden seizures, people with the condition would benefit greatly from a therapy that can detect seizures just as they are starting or, eventually, predict them before they begin and prevent them from happening. A new generation of implantable devices is looking to pick up where medications—and even the VNS—often leave off, at least for people whose seizures routinely begin in one part of the brain (the seizure focus). "Closed-loop" devices are designed to monitor the seizure focus, detect patterns of electrical activity that indicate a seizure is beginning, and quickly respond without external intervention. Such responses could include electrical stimulation, cooling or focused drug delivery—all meant to interrupt the activity and stop the seizure.

Closed-loop devices are considered a new frontier in epilepsy treatment because of their responsiveness. By comparison, the VNS is an open-loop device that stimulates the vagus nerve—a pair of nerves running from the brain stem to the abdomen—to deliver mild electrical pulses (which mitigate the electrical activity of seizures) to the brain on a consistent schedule rather than in response to detected seizure activity. The concept of a closed-loop device for epilepsy comes out of the cardiac world, jumping off from implanted defibrillators that monitor the heart and deliver stimulation in response to an event.

Responsive neurostimulation
So far, only one closed-loop device has reached human trials: NeuroPace's Responsive Neurostimulation System (RNS), an electrical-stimulation implant with two leads, each containing four electrodes, placed in the brain at the seizure focus. The RNS detects electrical activity that denotes the start of a seizure and delivers direct electrical stimulation to interrupt the activity and normalize the area. The device is surgically positioned in a section of the skull, can be accessed via outpatient surgery when the battery has to be changed, and is imperceptible to the patient and others—all strong design advantages for patients and doctors. The implant, which is now seeking FDA approval, also records information on electrical activity in the brain throughout the day for later review. The RNS has a laptop-based wand interface for remote patient monitoring.

Results of the RNS trials, which tested the implant in conjunction with medications, have been mixed: seizure frequency was reduced by about half in approximately 50 percent of patients. "For a patient to go though permanent implanting of the device on the skull, and electrodes over the brain, which is what is needed for RNS, you'd want it to eliminate most or all seizures, which isn't the result in most patients," says John Miller, director of the University of Washington School of Medicine's Regional Epilepsy Center at Harborview in Seattle. Possible ways to improve the device's effectiveness, Miller says, could include refining patient selection, improving electrode placement or honing the RNS's detection process so that it can pick up seizure activity earlier.

Work in closed-loop electrical stimulation is also happening at Boston’s Center for Integration of Medicine and Innovative Technology, where researchers are effectively attempting to turn the VNS into a closed-loop device by developing a nonimplanted add-on system to detect early seizure activity and automatically fire the VNS in response. The VNS comes with a therapy magnet wristband that allows wearers to stimulate the device if they feel a seizure coming on (a sensation called an aura), but not everyone is physically able to do so once the aura begins. The CIMIT system automates the process, activating the VNS once the start of a seizure is detected through electroencephalogram and electrocardiogram readings.

Cool it
Another key area of closed-loop research is focal cooling. Here, an implant—after detecting the onset of a seizure by sensing a rise in brain temperature at the seizure focus, which may slightly precede the start of abnormal electrical activity—rapidly cools the involved region to halt the event. The warming associated with the seizure focus makes thermal detection and cooling a potentially promising technique. One center of focal cooling research is the University of Kansas Medical Center, where Ivan Osorio, professor of neurology, has collaborated with an international research partnership to design a prototype implant with funding from the U.S. Department of Energy. Work on cooling is also in progress at other sites, including Yale University and the University of Minnesota.